SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
1.920
+0.020 (1.05%)
At close: Nov 11, 2026, 4:00 PM EST
1.860
-0.060 (-3.12%)
After-hours: Nov 11, 2026, 5:56 PM EST
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $615.00K in the quarter ending June 30, 2026, with 81.95% growth. This brings the company's total for the last twelve months to $1.71M, up 123.63% year-over-year. In the year 2025, SeaStar Medical Holding had annual revenue of $1.23M with 814.07% growth. That makes SeaStar Medical Holding the 42,699th largest company in the world by revenue and 5,850th in the United States.
Revenue (ttm)
$1.71M
Revenue Growth
+123.63%
P/S Ratio
5.84
Revenue / Employee
$95,167
Employees
18
Market Cap
10.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23M | 1.10M | 814.07% |
| Dec 31, 2024 | 135.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ICU News
- 1 hour ago - SeaStar Medical Holding Earnings Call Transcript: Q3 2026 - Transcripts
- 1 hour ago - SeaStar Medical Holding Earnings release: Q3 2026 - Filings
- 2 hours ago - SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 days ago - SeaStar Medical to Report Third Quarter Financial Results on November 11, 2026 - GlobeNewsWire
- 8 days ago - FDA confirms SeaStar Medical Quelimmune SAVE Registry fulfills requirements - TheFly
- 8 days ago - FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients - GlobeNewsWire
- 12 days ago - SeaStar Medical Holding Registration statement: Registration filing - Filings
- 20 days ago - SeaStar Medical reports findings from QUELIMMUNE SAVE registry analysis - TheFly